Viewing Study NCT00911300

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 12:19 PM
Ignite Modification Date: 2026-01-14 @ 2:42 AM
Study NCT ID: NCT00911300
Status: COMPLETED
Last Update Posted: 2012-10-01
First Post: 2009-05-28
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fibrillation, Atrial View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cardioversion, Electric View
None Pathological Conditions, Sings and Symptoms View
None Cardiovascular Diseases View
None Heart Diseases View
None Atrial Fibrillation View
None Arrhythmias, Cardiac View
None Pathologic Processes View
None Anticoagulants View